International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

Sally J  Wheelwright; A.S. Darlington; D Fitzsimmons; Peter Fayers; J. I. Arraras; F Bonnetain; E  Brain; A Bredart; W-C Chie; J Giesinger; E Hammerlid; S.J. O'Connor; S Oerlemans; A  Pallis; M Reed; N. Singhal; V Vsasilou; T Young; C Johnson; EORTC Quality of Life Group

doi:10.1038/bjc.2013.407

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

Sally J Wheelwright (Corresponding Author), A.S. Darlington, D Fitzsimmons, Peter Fayers, J. I. Arraras, F Bonnetain, E Brain, A Bredart, W-C Chie, J Giesinger, E Hammerlid, S.J. O'Connor, S Oerlemans, A Pallis, M Reed, N. Singhal, V Vsasilou, T Young, C Johnson, EORTC Quality of Life Group

Applied Health Sciences

Research output: Contribution to journal › Article › peer-review

79 Citations (Scopus)

14 Downloads (Pure)

Abstract

Background: Older people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC’s core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged >70 years in oncology studies.
Methods: Patients (n=518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test–retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA).
Results: Information from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test–retest and RCA analyses were equivocal.
Conclusion: The QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged 70 years. Changes in elderly patients’ self-reported HRQOL may be related to both cancer evolution and non-clinical events.

Original language	English
Pages (from-to)	852-858
Number of pages	7
Journal	British Journal of Cancer
Volume	109
Early online date	18 Jul 2013
DOIs	https://doi.org/10.1038/bjc.2013.407
Publication status	Published - 20 Aug 2013

Bibliographical note

ACKNOWLEDGEMENTS
This study was funded by the European Organisation for Research and Treatment of Cancer Quality of Life (EORTC QOL) Group who approved the manuscript before submission. We would like to thank the reviewers from the EORTC QOL group, Mogens Grønvold, Galina Velikova, Susanne Singer, Bernhard Holzner,
Eva Greimel, Jaap Reijneveld and Andrew Bottomley. The following all contributed to participant recruitment, for which we are grateful: Dr Valerie Quipourt, Dr Genevie`ve Imbert, Dr Bernhard Holzner, Dr Annemie Courtens, Dr Jessie Wu, Ms Anne Jacob, Ms Janet Prouse, Mrs Christine Brannan and Mrs Melanie Winterbotham. We acknowledge all the centres, investigators and patients who took time to participate in the study.

Keywords

health-related quality of life
elderly
European Organisation for Research and Treatment of Cancer QLQ-C30
module validation study

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/bjc.2013.407Licence: CC BY-NC-SA

IInternational validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer
This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution Non Commercial-Share Alike 3.0 Unported License. https://creativecommons.org/licenses/by-nc-sa/3.0/
Final published version, 158 KBLicence: CC BY-NC-SA

Cite this

Wheelwright, S. J., Darlington, A. S., Fitzsimmons, D., Fayers, P., Arraras, J. I., Bonnetain, F., Brain, E., Bredart, A., Chie, W.-C., Giesinger, J., Hammerlid, E., O'Connor, S. J., Oerlemans, S., Pallis, A., Reed, M., Singhal, N., Vsasilou, V., Young, T., Johnson, C., & EORTC Quality of Life Group (2013). International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. British Journal of Cancer, 109, 852-858. https://doi.org/10.1038/bjc.2013.407

Wheelwright, SJ, Darlington, AS, Fitzsimmons, D, Fayers, P, Arraras, JI, Bonnetain, F, Brain, E, Bredart, A, Chie, W-C, Giesinger, J, Hammerlid, E, O'Connor, SJ, Oerlemans, S, Pallis, A, Reed, M, Singhal, N, Vsasilou, V, Young, T, Johnson, C & EORTC Quality of Life Group 2013, 'International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer', British Journal of Cancer, vol. 109, pp. 852-858. https://doi.org/10.1038/bjc.2013.407

@article{6670f32866f444cfa87f699a905a5ea5,

title = "International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer",

abstract = "Background: Older people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC{\textquoteright}s core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged >70 years in oncology studies.Methods: Patients (n=518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test–retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA). Results: Information from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test–retest and RCA analyses were equivocal.Conclusion: The QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged 70 years. Changes in elderly patients{\textquoteright} self-reported HRQOL may be related to both cancer evolution and non-clinical events.",

keywords = "health-related quality of life, elderly, European Organisation for Research and Treatment of Cancer QLQ-C30, module validation study",

author = "Wheelwright, {Sally J} and A.S. Darlington and D Fitzsimmons and Peter Fayers and Arraras, {J. I.} and F Bonnetain and E Brain and A Bredart and W-C Chie and J Giesinger and E Hammerlid and S.J. O'Connor and S Oerlemans and A Pallis and M Reed and N. Singhal and V Vsasilou and T Young and C Johnson and {EORTC Quality of Life Group}",

note = "ACKNOWLEDGEMENTS This study was funded by the European Organisation for Research and Treatment of Cancer Quality of Life (EORTC QOL) Group who approved the manuscript before submission. We would like to thank the reviewers from the EORTC QOL group, Mogens Gr{\o}nvold, Galina Velikova, Susanne Singer, Bernhard Holzner, Eva Greimel, Jaap Reijneveld and Andrew Bottomley. The following all contributed to participant recruitment, for which we are grateful: Dr Valerie Quipourt, Dr Genevie`ve Imbert, Dr Bernhard Holzner, Dr Annemie Courtens, Dr Jessie Wu, Ms Anne Jacob, Ms Janet Prouse, Mrs Christine Brannan and Mrs Melanie Winterbotham. We acknowledge all the centres, investigators and patients who took time to participate in the study.",

year = "2013",

month = aug,

day = "20",

doi = "10.1038/bjc.2013.407",

language = "English",

volume = "109",

pages = "852--858",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

AU - Wheelwright, Sally J

AU - Darlington, A.S.

AU - Fitzsimmons, D

AU - Fayers, Peter

AU - Arraras, J. I.

AU - Bonnetain, F

AU - Brain, E

AU - Bredart, A

AU - Chie, W-C

AU - Giesinger, J

AU - Hammerlid, E

AU - O'Connor, S.J.

AU - Oerlemans, S

AU - Pallis, A

AU - Reed, M

AU - Singhal, N.

AU - Vsasilou, V

AU - Young, T

AU - Johnson, C

AU - EORTC Quality of Life Group

N1 - ACKNOWLEDGEMENTS This study was funded by the European Organisation for Research and Treatment of Cancer Quality of Life (EORTC QOL) Group who approved the manuscript before submission. We would like to thank the reviewers from the EORTC QOL group, Mogens Grønvold, Galina Velikova, Susanne Singer, Bernhard Holzner, Eva Greimel, Jaap Reijneveld and Andrew Bottomley. The following all contributed to participant recruitment, for which we are grateful: Dr Valerie Quipourt, Dr Genevie`ve Imbert, Dr Bernhard Holzner, Dr Annemie Courtens, Dr Jessie Wu, Ms Anne Jacob, Ms Janet Prouse, Mrs Christine Brannan and Mrs Melanie Winterbotham. We acknowledge all the centres, investigators and patients who took time to participate in the study.

PY - 2013/8/20

Y1 - 2013/8/20

N2 - Background: Older people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC’s core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged >70 years in oncology studies.Methods: Patients (n=518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test–retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA). Results: Information from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test–retest and RCA analyses were equivocal.Conclusion: The QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged 70 years. Changes in elderly patients’ self-reported HRQOL may be related to both cancer evolution and non-clinical events.

AB - Background: Older people represent the majority of cancer patients but their specific needs are often ignored in the development of health-related quality of life (HRQOL) instruments. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-ELD15 was developed to supplement the EORTC’s core questionnaire, the QLQ-C30, for measuring HRQOL in patients aged >70 years in oncology studies.Methods: Patients (n=518) from 10 countries completed the QLQ-C30, QLQ-ELD15 and a debriefing interview. Eighty two clinically stable patients repeated the questionnaires 1 week later (test–retest analysis) and 107 others, with an expected change in clinical status, repeated the questionnaires 3 months later (response to change analysis, RCA). Results: Information from the debriefing interview, factor analysis and item response theory analysis resulted in the removal of one item (QLQ-ELD15QLQ-ELD14) and revision of the proposed scale structure to five scales (mobility, worries about others, future worries, maintaining purpose and illness burden) and two single items (joint stiffness and family support). Convergent validity was good. In known-group comparisons, the QLQ-ELD14 differentiated between patients with different disease stage, treatment intention, number of comorbidities, performance status and geriatric screening scores. Test–retest and RCA analyses were equivocal.Conclusion: The QLQ-ELD14 is a validated HRQOL questionnaire for cancer patients aged 70 years. Changes in elderly patients’ self-reported HRQOL may be related to both cancer evolution and non-clinical events.

KW - health-related quality of life

KW - elderly

KW - European Organisation for Research and Treatment of Cancer QLQ-C30

KW - module validation study

U2 - 10.1038/bjc.2013.407

DO - 10.1038/bjc.2013.407

M3 - Article

SN - 0007-0920

VL - 109

SP - 852

EP - 858

JO - British Journal of Cancer

JF - British Journal of Cancer

ER -

International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this